Gallet M, Aupetit J F, Lopez M, Manchon J, Lestaevel M, Lefrançois J J
Arch Mal Coeur Vaiss. 1986 Jul;79(8):1216-20.
In order to determine the interaction between diltiazem and digoxin, plasma digoxin concentrations and the principal ECG parameters (24 hour Holter monitoring) were measured in 10 healthy volunteers under basal conditions (P0), with 0.375 mg/day of digoxin (P1 = 17 days), during association with 240 mg/day of diltiazem (P2 = 17 days) and then again on digoxin alone (P3 = 10 days). The addition of diltiazem was associated with a 20.4% rise in plasma digoxin concentrations (0.59 ng/ml vs 0.49 ng.ml). There was no significant variation of plasma digoxin after withdrawal of diltiazem; in some cases it remained unchanged, in others it fell or continued to rise. During the administration of digoxin and diltiazem, the mean RR period and the duration of the maximal pauses increased (p less than 0.05); the RR interval also increased (p less than 0.01) but the mean QRS duration and the QTc interval did not change significantly with respect to their values on digoxin alone. After withdrawal of diltiazem, the PR interval was the only parameter to decrease significantly (p less than 0.05). These results suggest that patients receiving this drug association should be followed up carefully.
为了确定地尔硫䓬与地高辛之间的相互作用,对10名健康志愿者在基础状态(P0)下、服用0.375毫克/天地高辛时(P1 = 17天)、联合服用240毫克/天地尔硫䓬时(P2 = 17天)以及之后再次单独服用地高辛时(P3 = 10天)的血浆地高辛浓度和主要心电图参数(24小时动态心电图监测)进行了测量。添加地尔硫䓬后,血浆地高辛浓度升高了20.4%(从0.49纳克/毫升升至0.59纳克/毫升)。停用 地尔硫䓬后,血浆地高辛浓度无显著变化;在某些情况下保持不变,在另一些情况下则下降或继续上升。在服用地高辛和地尔硫䓬期间,平均RR间期和最大停顿时间增加(p<0.05);RR间期也增加(p<0.01),但平均QRS时限和QTc间期与单独服用地高辛时的值相比无显著变化。停用 地尔硫䓬后,PR间期是唯一显著降低的参数(p<0.05)。这些结果表明,接受这种药物联合治疗的患者应进行仔细随访。